Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheryl K Elkin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|August 7, 2018
Making the right calls in precision oncologyKathryn D Bungartz, Kristen Lalowski, Sheryl K Elkin
The Journal of Biological Chemistry|June 18, 2004
ATP-dependent remodeling by SWI/SNF and ISWI proteins stimulates V(D)J cleavage of 5 S arraysNadja Patenge, Sheryl K Elkin, Marjorie A Oettinger
The EMBO Journal|April 12, 2003
The C-terminal portion of RAG2 protects against transposition in vitroSheryl K Elkin, Adam G Matthews, Marjorie A Oettinger
The EMBO Journal|February 28, 2004
Ordered DNA release and target capture in RAG transpositionAdam G W Matthews, Sheryl K Elkin, Marjorie A Oettinger
Cell Cycle (Georgetown, Tex.)|June 2, 2015
Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor typesMaria Schwaederle, Sheryl K Elkin, Brett N Tomson, et al.
Cancer Biology & Therapy|October 20, 2018
Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testingSadakatsu Ikeda, Sheryl K Elkin, Brett N Tomson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
<i>RET</i> Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 PatientsShumei Kato, Vivek Subbiah, Erica Marchlik, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2013
Polo kinase Cdc5 is a central regulator of meiosis IMichelle A Attner, Matthew P Miller, Ly-sha Ee, et al.
Oncotarget|March 17, 2016
Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeuticsPhilip R Cohen, Brett N Tomson, Sheryl K Elkin, et al.
Oncotarget|August 7, 2015
Genomic landscape of salivary gland tumorsShumei Kato, Sheryl K Elkin, Maria Schwaederle, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|August 7, 2018
Making the right calls in precision oncologyKathryn D Bungartz, Kristen Lalowski, Sheryl K Elkin
The Journal of Biological Chemistry|June 18, 2004
ATP-dependent remodeling by SWI/SNF and ISWI proteins stimulates V(D)J cleavage of 5 S arraysNadja Patenge, Sheryl K Elkin, Marjorie A Oettinger
The EMBO Journal|April 12, 2003
The C-terminal portion of RAG2 protects against transposition in vitroSheryl K Elkin, Adam G Matthews, Marjorie A Oettinger
The EMBO Journal|February 28, 2004
Ordered DNA release and target capture in RAG transpositionAdam G W Matthews, Sheryl K Elkin, Marjorie A Oettinger
Cell Cycle (Georgetown, Tex.)|June 2, 2015
Squamousness: Next-generation sequencing reveals shared molecular features across squamous tumor typesMaria Schwaederle, Sheryl K Elkin, Brett N Tomson, et al.
Cancer Biology & Therapy|October 20, 2018
Next-generation sequencing of prostate cancer: genomic and pathway alterations, potential actionability patterns, and relative rate of use of clinical-grade testingSadakatsu Ikeda, Sheryl K Elkin, Brett N Tomson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
<i>RET</i> Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 PatientsShumei Kato, Vivek Subbiah, Erica Marchlik, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 7, 2013
Polo kinase Cdc5 is a central regulator of meiosis IMichelle A Attner, Matthew P Miller, Ly-sha Ee, et al.
Oncotarget|March 17, 2016
Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeuticsPhilip R Cohen, Brett N Tomson, Sheryl K Elkin, et al.
Oncotarget|August 7, 2015
Genomic landscape of salivary gland tumorsShumei Kato, Sheryl K Elkin, Maria Schwaederle, et al.
Pageof 2